However, I think that connection [manufacturing in China?]might make infringement difficult to prove, i.e. how can MNTA prove infringement done by Amphastar Nanjing Pharma?
Unlikely since they will have had to be transparent with the FDA - so at the very least a subpoena to the FDA would produce the answer.
Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.